Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia.

Trial Profile

Efficacy of Olanzapine in Improving Task Engagement in Schizophrenia.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 26 Dec 2013

At a glance

  • Drugs Olanzapine (Primary) ; Antipsychotics
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Dec 2013 Status changed from completed to withdrawn prior to recruitment as per ClinicalTrials.gov record
    • 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Mar 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top